Solu-medrol Injection, Powder, For Solution
Product Images NDC 0404-9957

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Solu-medrol (NDC 0404-9957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
Preservative-free formulations of Act-O-Vial system in four different dosages are available. The Act-O-Vial system is a single-dose vial containing methylprednisolone sodium succinate along with other ingredients in varying amounts. The dosages available are 40 mg, 125 mg, 500 mg, and 1 gram. The ingredients also include monobasic sodium phosphate anhydrous, dibasic sodium phosphate dried, and lactose hydrous in some cases.*
FDA Label Image

Image2.jpg (Image2)

Image2.jpg (Image2)
These are different vials of methylprednisolone sodium succinate which are mixed with diluents containing benzyl alcohol as a preservative. The vials contain different doses of methylprednisolone and phosphate anhydrous and dibasic sodium phosphate dried. The package for 2 gram vial also contains the recommended diluent.*
FDA Label Image

Image3.jpg (Image3)

Image3.jpg (Image3)
This text is a warning regarding the reconstitution of SOLU-MEDROL. It instructs the reader to use either the provided diluent or Bacteriostatic Water For Injection along with Benzyl Alcohol, and to use the mixture within 48 hours of mixing.*
FDA Label Image

Image4.jpg (Image4)

Image4.jpg (Image4)
This text provides a comparison of the milligram dosage of various glucocorticoids such as cortisone, hydrocortisone, prednisolone, and Betamethasone, among others. It highlights that the dosage applies to oral or intravenous administration only and the properties of these compounds may differ greatly when injected intramuscularly or into joint spaces.*
FDA Label Image

Image5.jpg (Image5)

FDA Label Image

Label1.jpg (Label1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.